Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 12/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31323823 | 0.87 | SMN1; SMN2 (0.38) | MEN1MAPTKMT2AATMSMN1; SMN2 | |
| SCHEMBL31323937 | 0.85 | SMN1; SMN2 (0.37) | MEN1MAPTKMT2AATMSMN1; SMN2 | |
| SCHEMBL31323932 | 0.83 | ALDH1A1 (0.32) | MAPTALDH1A1 | |
| SCHEMBL27299469 | 0.81 | TLR2 (0.33) | MAPTNAAA | |
| SCHEMBL31323848 | 0.76 | SMN1; SMN2 (0.34) | SMN1; SMN2EPHX1NAAAALDH1A1 | |
| SCHEMBL27299109 | 0.74 | TLR2 (0.33) | — | |
| SCHEMBL16380566 | 0.73 | SMN1; SMN2 (0.44) | MEN1MAPTKMT2AATMSMN1; SMN2 | |
| SCHEMBL31323958 | 0.72 | CHRM2 (0.40) | SMN1; SMN2 | |
| SCHEMBL27299467 | 0.72 | TLR2 (0.32) | MAPTNAAA | |
| SCHEMBL27299461 | 0.72 | TLR2 (0.35) | MAPTNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025035202-A1 | IONIZABLE LIPIDS COMPRISING MACROCYCLIC RINGS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2025-02-20 | — | — | WO | disclosed |